
Keywords: urinary bladder neoplasms; neoadjuvant therapy; cystectomy; time factorsGC, gemcitabine and cisplatin; MIBC, muscle invasive bladder cancer; MVAC, methotrexate, vinblastine, doxorubicin and cisplatin; NAC, neoadjuvant chemotherapy; OS, overall survival; R